Published in Thorax on May 01, 1994
Health status measurement in chronic obstructive pulmonary disease. Thorax (2001) 3.07
Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax (1997) 2.91
Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax (1996) 1.94
Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med (2012) 1.80
Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD. Prim Care Respir J (2012) 1.45
Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax (1995) 1.35
Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD. Respir Med (2010) 1.22
Promotion of lung health: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc (2014) 0.93
Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomized controlled trials on pulmonary rehabilitation. Clin Epidemiol (2010) 0.89
Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD? Respir Res (2011) 0.85
Concerns about exercise are related to walk test results in pulmonary rehabilitation for patients with COPD. Int J Behav Med (2012) 0.83
The relationship between anthropometric indicators and walking distance in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.80
Association Between 6-Minute Walk Test and All-Cause Mortality, Coronary Heart Disease-Specific Mortality, and Incident Coronary Heart Disease. J Aging Health (2014) 0.80
Does mild COPD affect prognosis in the elderly? BMC Pulm Med (2010) 0.80
Fatigue and multidimensional disease severity in chronic obstructive pulmonary disease. Multidiscip Respir Med (2010) 0.79
Effects of formoterol inhaled dry powder on exercise performance in chronic obstructive pulmonary disease: a single-center, randomized, double-blind, placebo-controlled, crossover study. Curr Ther Res Clin Exp (2003) 0.77
Correlation of severity of chronic obstructive pulmonary disease with health-related quality of life and six-minute walk test in a rural hospital of central India. Lung India (2015) 0.77
Correlation of cardiopulmonary exercise testing parameters with quality of life in stable COPD patients. J Thorac Dis (2016) 0.77
Sit-to-stand test and 6-min walking test correlation in patients with chronic obstructive pulmonary disease. Ann Thorac Med (2015) 0.75
Determinants of distance walked during the six-minute walk test in patients undergoing cardiac surgery at hospital discharge. J Cardiothorac Surg (2014) 0.75
Functional outcomes in patients with chronic obstructive pulmonary disease: a multivariate analysis. Braz J Phys Ther (2014) 0.75
Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD. Int J Chron Obstruct Pulmon Dis (2014) 0.75
Correlation of a decline in aerobic capacity with development of emphysema in patients with chronic obstructive pulmonary disease: a prospective observational study. PLoS One (2015) 0.75
Six-Minute Walk Test in Renal Failure Patients: Representative Results, Performance Analysis and Perceived Dyspnea Predictors. PLoS One (2016) 0.75
Psychophysical bases of perceived exertion. Med Sci Sports Exerc (1982) 30.13
Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J (1976) 14.74
A measure of quality of life for clinical trials in chronic lung disease. Thorax (1987) 10.87
Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) (1982) 7.77
Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis (1969) 6.00
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest (1984) 5.19
Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J (1978) 4.93
How should we measure function in patients with chronic heart and lung disease? J Chronic Dis (1985) 2.61
Performance, ventilation, and oxygen consumption in three different types of exercise test in patients with chronic obstructive lung disease. Thorax (1985) 2.47
The use of the 12 minute walking test in assessing the effect of oral steroid therapy in patients with chronic airways obstruction. Br J Dis Chest (1982) 1.75
Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax (1993) 1.16
The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N Engl J Med (1984) 1.10
Target-flow inspiratory muscle training during pulmonary rehabilitation in patients with COPD. Chest (1991) 1.08
A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1992) 1.07
Predicting maximal exercise ventilation in patients with chronic obstructive pulmonary disease. Chest (1987) 1.00
Psychological factors contributing to disproportionate disability in chronic bronchitis. J Psychosom Res (1983) 0.96
Measurement of dyspnoea in chronic obstructive pulmonary disease. Qual Life Res (1993) 0.89
Exercise tolerance in chronic obstructive pulmonary disease: importance of active and passive components of the ventilatory system. Eur Respir J (1989) 0.82
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03
Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med (2000) 6.34
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med (1999) 4.65
Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax (1999) 4.11
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis (1985) 3.77
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J (2005) 3.66
Air pollution and development of asthma, allergy and infections in a birth cohort. Eur Respir J (2007) 3.42
A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med (1992) 3.13
Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol (2002) 3.02
Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax (1999) 3.00
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax (2004) 2.85
Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol (1985) 2.76
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Lancet (2001) 2.68
Asthma at 8 years of age in children born by caesarean section. Thorax (2008) 2.45
PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med (2001) 2.36
Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis (1986) 2.29
Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J (2008) 2.23
Severe exacerbations predict excess lung function decline in asthma. Eur Respir J (2007) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med (2001) 2.08
Inhaled corticosteroids in COPD: a case in favour. Eur Respir J (2009) 2.06
Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis. Eur Respir J (1995) 2.06
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J (2004) 2.05
Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax (1997) 2.04
Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax (2000) 2.02
Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med (2001) 1.99
Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax (1992) 1.98
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96
Effects of long-term treatment with corticosteroids in COPD. Chest (1996) 1.94
Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J (1994) 1.91
Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J (2007) 1.90
Childhood factors associated with asthma remission after 30 year follow up. Thorax (2004) 1.90
Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax (1994) 1.84
Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics (1994) 1.81
Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet (2000) 1.78
[Is pneumonia of unknown origin yet a pneumococcal pneumonia sometimes?]. Ned Tijdschr Geneeskd (1992) 1.72
Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. J Rheumatol (1993) 1.71
Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma. Allergy (2010) 1.70
Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol (2001) 1.65
Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. Clin Sci (Lond) (1985) 1.64
Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet (2000) 1.63
Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy. Eur Respir J (2005) 1.62
Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax (2005) 1.60
No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux. Eur Respir J (1998) 1.60
Particle size matters: diagnostics and treatment of small airways involvement in asthma. Eur Respir J (2010) 1.58
The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J (1991) 1.57
Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy (2004) 1.55
Assessment of airway inflammation: an overview. Eur Respir J Suppl (1998) 1.55
Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches. Transplantation (2001) 1.55
Changes in respiratory symptoms and airway hyperresponsiveness after 27 years in a population-based sample of school children. Eur Respir J (1993) 1.54
Influence of in vivo prednisolone on increased in vitro O2- generation by neutrophils in emphysema. Eur Respir J (1993) 1.54
Analysis of survival and morbidity after pediatric liver transplantation with full-size and technical-variant grafts. Transplantation (1999) 1.52
Childhood overweight and asthma symptoms, the role of pro-inflammatory proteins. Clin Exp Allergy (2011) 1.52
Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med (1999) 1.52
Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands. Int J Tuberc Lung Dis (2000) 1.51
Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax (2003) 1.51
Pesticides and other occupational exposures are associated with airway obstruction: the LifeLines cohort study. Occup Environ Med (2013) 1.50
Conventional RIA underestimates cortisol suppression in the presence of prednisolone. Thorax (2002) 1.50
Less small airway dysfunction in asymptomatic bronchial hyperresponsiveness than in asthma. Allergy (2013) 1.48
European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J (1992) 1.47
Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response. Allergy (2007) 1.47
Risk factors for atopic dermatitis in infants at high risk of allergy: the PIAMA study. Clin Exp Allergy (2003) 1.46
Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD. Respir Med (2006) 1.45
The importance of serum IgE for level and longitudinal change in airways hyperresponsiveness in COPD. Clin Exp Allergy (1998) 1.44
Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy (2005) 1.44
Indirect airway challenges. Eur Respir J (2003) 1.42
Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy (1996) 1.41
[Current viewpoints concerning antibiotic treatment in COPD patients]. Ned Tijdschr Geneeskd (1994) 1.41
[Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma]. Ned Tijdschr Geneeskd (2006) 1.40
Exclusion of chromosome 11q and the FcepsilonRI-beta gene as aetiological factors in allergy and asthma in a population of Dutch asthmatic families. Clin Exp Allergy (1998) 1.40